Home › Funds › Soleus Capital Management, L.P. › PRAX

Soleus Capital Management, L.P. position in PRAX

PRAXIS PRECISION MEDICINES I · Health Care

Soleus Capital Management, L.P. reported holding 177,517 shares of PRAX (PRAXIS PRECISION MEDICINES I) in its Q2 2026 13F filing — a position valued at US$59.4M, representing 2.05% of its reported portfolio and ranking #12 among its reported holdings. Soleus Capital Management, L.P. has disclosed PRAX holdings in 11 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)177.52K sh
Reported value held$59.43M
Portfolio Weight2.05%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Soleus Capital Management, L.P.'s PRAX position evolved

Soleus Capital Management, L.P. first disclosed a stake in PRAX in Q3 2023 at 1,150,000 shares (US$2.0M). The position peaked in Q4 2025 at 362,966 shares, worth US$107.0M. Across 11 filings, Soleus Capital Management, L.P. increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 177,517 shares valued at US$59.4M — a reduction of -153,000 shares quarter over quarter.. Notable position changes include a 1330% increase in Q2 2024 (shares rose 39% over the following quarter), a 368% increase in Q1 2025 (shares rose 11% over the following quarter), a 58% trim in Q4 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.15M $1.97M New
Q1 2024 37.27K $2.27M New
Q2 2024 533.01K $22.05M Add
Q3 2024 259.40K $14.93M Reduce
Q4 2024 243.54K $18.74M Reduce
Q1 2025 1.14M $43.16M Add
Q2 2025 966.74K $40.65M Reduce
Q3 2025 859.17K $45.54M Reduce
Q4 2025 362.97K $106.98M Reduce
Q1 2026 330.52K $106.49M Reduce
Q2 2026 177.52K $59.43M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRAX and 13F data

PRAX (PRAXIS PRECISION MEDICINES I) is a Health Care company. 73 other funds we track also report a position in PRAX — the largest reported positions include Jupiter Topco LLC (US$1.15B), Janus Henderson Group (US$1.11B), PERCEPTIVE ADVISORS LLC (US$681.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRAX

All PRAX fund holders →

FAQ

How long has Soleus Capital Management, L.P. held PRAX?

Soleus Capital Management, L.P. has disclosed PRAX holdings in 11 of the last 12 reported quarters, going back to Q3 2023.

What is Soleus Capital Management, L.P.'s current position in PRAX?

As of Q2 2026, Soleus Capital Management, L.P. holds 177.52K shares of PRAX (PRAXIS PRECISION MEDICINES I), valued at $59.43M, representing 2.05% of its reported portfolio and ranking #12.

Has Soleus Capital Management, L.P. been buying or selling PRAX?

In the latest 13F filing (Q2 2026), Soleus Capital Management, L.P. reduced its position in PRAX. The position peaked in Q4 2025 at 362.97K shares.

Which other funds hold PRAX?

Other major institutional holders of PRAX include Jupiter Topco LLC, Janus Henderson Group, PERCEPTIVE ADVISORS LLC, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.